Atlas Trials

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

Clinical trial NCT02576561 · UNKNOWN

Trial details

NCT number
NCT02576561
Sponsor
THEVAX Genetics Vaccine
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Human PapillomavirusHigh-Grade Squamous Intraepithelial Lesions
Start date
2015-11-01
Primary completion
2018-05-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.